Business Description
Cellid Co Ltd
ISIN : KR7299660001
Share Class Description:
XKRX:299660: Ordinary SharesCompare
Compare
Traded in other countries / regions
299660.Korea IPO Date
2019-02-20Description
Cellid Co Ltd is a research and development bioventure company. The company is developing immunotherapeutic vaccines, CeliVax. The CeliVax is a personalized vaccine which uses patient's own cells.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.29 | |||||
| Equity-to-Asset | 0.63 | |||||
| Debt-to-Equity | 0.3 | |||||
| Debt-to-EBITDA | -1.56 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -29.5 | |||||
| 3-Year EPS without NRI Growth Rate | -45 | |||||
| 3-Year FCF Growth Rate | -6.8 | |||||
| 3-Year Book Growth Rate | -11.3 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 47.97 | |||||
| 9-Day RSI | 45.44 | |||||
| 14-Day RSI | 45.61 | |||||
| 6-1 Month Momentum % | 14.33 | |||||
| 12-1 Month Momentum % | -46.47 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.63 | |||||
| Quick Ratio | 1.63 | |||||
| Cash Ratio | 1.49 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -7 | |||||
| Shareholder Yield % | 9.66 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -45.61 | |||||
| ROA % | -25.58 | |||||
| ROIC % | -28.87 | |||||
| ROC (Joel Greenblatt) % | -40.99 | |||||
| ROCE % | -32.78 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 1.31 | |||||
| Price-to-Tangible-Book | 1.46 | |||||
| EV-to-EBIT | -4.79 | |||||
| EV-to-EBITDA | -6.44 | |||||
| EV-to-FCF | -2.65 | |||||
| Earnings Yield (Greenblatt) % | -20.87 | |||||
| FCF Yield % | -34.73 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cellid Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | |||
| EPS (TTM) (â‚©) | -991.035 | ||
| Beta | 2.28 | ||
| Volatility % | 63.54 | ||
| 14-Day RSI | 45.61 | ||
| 14-Day ATR (â‚©) | 211.464684 | ||
| 20-Day SMA (â‚©) | 4033.5 | ||
| 12-1 Month Momentum % | -46.47 | ||
| 52-Week Range (â‚©) | 3100 - 8184.857873 | ||
| Shares Outstanding (Mil) | 13.6 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cellid Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cellid Co Ltd Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Cellid Co Ltd Frequently Asked Questions
What is Cellid Co Ltd(XKRX:299660)'s stock price today?
The current price of XKRX:299660 is â‚©3895.00. The 52 week high of XKRX:299660 is â‚©8184.86 and 52 week low is â‚©3100.00.
When is next earnings date of Cellid Co Ltd(XKRX:299660)?
The next earnings date of Cellid Co Ltd(XKRX:299660) is .
Does Cellid Co Ltd(XKRX:299660) pay dividends? If so, how much?
Cellid Co Ltd(XKRX:299660) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers